Disciplined Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18
| Closed | -$127 | – | 254 |
|
|
2023
Q2 | $127 | Buy |
18
+11
| +157% | +$78 | ﹤0.01% | 1572 |
|
|
2023
Q1 | $58 | Sell |
7
-11
| -61% | -$91 | ﹤0.01% | 1622 |
|
|
2022
Q4 | $207 | Sell |
18
-2
| -10% | -$23 | ﹤0.01% | 1426 |
|
|
2022
Q3 | $0 | Buy |
20
+15
| +300% | – | ﹤0.01% | 1237 |
|
|
2022
Q2 | $0 | Sell |
5
-7
| -58% | – | ﹤0.01% | 1268 |
|
|
2022
Q1 | $0 | Buy |
+12
| New | – | ﹤0.01% | 1340 |
|